Author(s):
Parimal Verma, Dolly Dewangan, Jitendra Yadav, Kamraj, Krity Gupta, Manish Kumar Sahu, Prashant Kumar Sahu, Shweta Sinha, Preeti K. Suresh, S. J. Daharwal
Email(s):
Email ID Not Available
DOI:
10.52711/2321-581X.2025.00019 
Address:
Parimal Verma*, Dolly Dewangan, Jitendra Yadav, Kamraj, Krity Gupta, Manish Kumar Sahu, Prashant Kumar Sahu, Shweta Sinha, Preeti K. Suresh, S. J. Daharwal
University Institute of Pharmacy, Pt. Ravishankar Shukla University, Raipur (C.G).
*Corresponding Author
Published In:
Volume - 16,
Issue - 4,
Year - 2025
ABSTRACT:
Valacyclovir hydrochloride is an antiviral prodrug that can be administered orally to increase the bioavailability of Acyclovir. Treatment for transplant patients includes herpes simplex (HSV-1, HSV-2), herpes zoster, varicella zoning, and CMV prophylaxis. The drug when taken orally, rapidly transforms into acyclovir, which inhibits viral DNA polymerase and stops viral replication. RP-HPLC and UV-Visible spectrophotometry are one of those analytical techniques used to estimate Valacyclovir in bulk, tablet formulations, and biological samples with high accuracy. These methods have the advantage of being linear, sensitive, and recoverable for use in routine quality control and pharmacokinetic studies. The purpose of this review is to provide better knowledge about valacyclovir, covering its chemistry, pharmacology, therapeutic uses, safety profile, and future perspectives in antiviral therapy.
Cite this article:
Parimal Verma, Dolly Dewangan, Jitendra Yadav, Kamraj, Krity Gupta, Manish Kumar Sahu, Prashant Kumar Sahu, Shweta Sinha, Preeti K. Suresh, S. J. Daharwal. A Review on Analytical Methods for Estimation of Valacyclovir Antiviral Drug. Research Journal of Engineering and Technology. 2025; 16(4):179-5. doi: 10.52711/2321-581X.2025.00019
Cite(Electronic):
Parimal Verma, Dolly Dewangan, Jitendra Yadav, Kamraj, Krity Gupta, Manish Kumar Sahu, Prashant Kumar Sahu, Shweta Sinha, Preeti K. Suresh, S. J. Daharwal. A Review on Analytical Methods for Estimation of Valacyclovir Antiviral Drug. Research Journal of Engineering and Technology. 2025; 16(4):179-5. doi: 10.52711/2321-581X.2025.00019 Available on: https://ijersonline.org/AbstractView.aspx?PID=2025-16-4-7
REFERENCES:
1. Ormrod, D. and Goa, K. Valaciclovir: a review of its use in the management of herpes zoster. Drugs. 2000; 59(6): 1317-1340.
2. Perry CM, Faulds D. Valaciclovir: a review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections. Drugs. 1996 Nov; 52: 754-72.
3. Vigil, K.J. and Chemaly, R.F. Valacyclovir: approved and off-label uses for the treatment of herpes virus infections in immunocompetent and immunocompromised adults. Expert opinion on pharmacotherapy.2010; 11(11), pp.1901-1913.
4. Ormrod DJ, Scott LJ, Perry CM. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections. Drugs 2000; 59 : 839-63.
5. Teva Canada Limited. (2016). Valacyclovir Hydrochloride Tablets — Product Monograph. Toronto, Ontario: Health Canada — Therapeutic Products Directorate.
6. Gilman, A. G.; Rail, T. W.; Nies, A. S.; Taylor, P. In The Pharmacological Basis of Therapeutics, 8th ed.; Pergamon: Oxford, 1990.
7. Beutner KR. Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy. Antiviral Res 1995; 28 (4): 281-90.
8. Wagstaff AJ, Faulds D, Goa KL. Aciclovir: a reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1994; 47 (1): 153-205.
9. Reusser P. Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options. J Hosp Infect 1996 Aug; 33: 235-48.
10. Morfin F, Thouvenot D, de Tourenne-Tessier M, et al. Phenotypic and genetic characterization of thymidine kinase from clinical strains of varicella-zoster virus resistant to acyclovir. Antimicrob Agents Chemother 1999; 43 (10): 2412-6.
11. Reusser P, Cordonnier C, Einsele H, et al. European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Bone Marrow Transplant 1996; 17: 813-7.
12. Beutner KR, Friedman DJ, Forszpaniak C, et al. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother. 1995 Jul; 39: 1546-53.
13. Weller S, Blum MR, Doucette M, et al. Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers. Clin Pharmacol Ther 1993 Dec; 54: 595-605.
14. Soul-Lawton J, Seaber E, On N, et al. Absolute bioavailability and metabolic disposition of valaciclovir, the l-valyl ester of acyclovir, following oral administration to humans. Antimicrob Agents Chemother 1995 Dec; 39: 2759-64.
15. Azuma J, Yamamoto I, Aoki T, et al. A phase I study of a new antiviral drug, valaciclovir hydrochloride (256U87), in healthy male volunteers [in Japanese]. Rinsho Iyaku 1998; 14 (15): 2683-700.
16. Vigil, K. J. and Chemaly, R. F. ‘Valacyclovir: approved and off-label uses for the treatment of herpes virus infections in immunocompetent and immunocompromised adults’, Expert Opinion on Pharmacotherapy,2010; 11(11), pp. 1901–1913. doi: 10.1517/14656566.2010.494179.
17. Beauchamp, L. M.; Orr, G. F.; deMiranda, P.; Burnette, T.; Krenitsky, T. A. Antiviral Chem. Chemother. 1992; 3, 157.
18. Ravisankar P, Navya CN, Pravallika D, Sri DN. A review on stepby-step analytical method validation. IOSR J Pharm 2015; 5:7-19.
19. 19)Patel A, Dwivedi N, Kaurav N, Bashani S, Patel S, Sharma HS, et al. Chemical analysis of pharmaceuticals: a review. J Med Pharm Innov 2016; 3:4-7.
20. Behera, S., Ghanty, S., Ahmad, F., Santra, S. and Banerjee, S. UV-visible spectrophotometric method development and validation of assay of paracetamol tablet formulation. J Anal Bioanal Techniques,2012; 3(6), pp.151-7.
21. Reddy, D.P., Gurupadayya, B.M., Manohara, Y.N. and Bhaskar, V.V. Spectrophotometric determination of valacyclovir hydrochloride in bulk and pharmaceutical formulations. Asian Journal of Chemistry,2007; 19(4), p.2797.
22. Bhavya Sri, K., Vaishnavi, A., Pravallika, J. and Sumakanth, M. RP-HPLC-UV method for estimation of antiviral drug (Valaciclovir) in pure, solid dosage form and spiked human plasma using MBTH reagent as per ICH guidelines. Accreditation and Quality Assurance, 2025; pp.1-11.
23. Tarinc, D. and Golcu, A. A simple spectrophotometric procedure for determination of valaciclovir in dosage forms and biological fluids. Journal of Analytical Chemistry, 68(1), 2013; pp.27-32.
24. Ramakrishna V, Ravi Kumar D, Rao NVN, Babu C. Method development and determination of valacyclovir hydrochloride in pharmaceutical dosage forms by visible spectrophotometry. Int J PharmTech Res. 2012; 4:1009–1014.
25. Sahu S, Patro S, Giri R. Method development and validation of valacyclovir in bulk and tablet dosage form by spectrophotometric and non-aqueous potentiometric method. World J Pharm Res. 2022;11(4):1240–1256. doi:10.20959/Wjpr20224-23400.
26. Shailesh S. Chalikwar, Kailas K. Moravakar, Bhushan A. Bhairav. Stability Indicating Method Development and Validation for Estimation of Valacyclovir in Pharmaceutical Preparation. Asian Journal of Pharmaceutical Analysis. 2024; 14(2):53-9. doi: 10.52711/2231-5675.2024.00010
27. Gurupadayya, B.M. and Prasadreddy, D.V. and Manohara, Y N and Vijayabhaskar, V. Spectrophotometric Determination of Valacyclovir Hydrochloride in Bulk and Pharmaceutical Formulations. Asian Journal of Chemistry. 2007;19.2797-2800.
28. Gupta, S., Verma, P., Mishra, A.P., Omar, N. and Mathur, R. A review on novel analytical method development and validation by RP-HPLC method. Indian Journal of Forensic Medicine and Toxicology, 2021;15(4), pp.3479-3486.
29. Srinivasa Rao K, Sunil M. Stability-indicating liquid chromatographic method for valacyclovir. Int J ChemTech Res. 2009;1(3):702–708.
30. Srinu Babu G, Ramesh K, Reddy YP, Reddy MN. Development and validation of a RP-HPLC method for the determination of valacyclovir hydrochloride in bulk drug and pharmaceutical dosage form. Asian J Chem. 2007;19(4):2797–2804.
31. Sri, Dr.K. and Lavanya, M.V.S. and Amuktha, K. and Sumakanth, M. Method Development, Validation and Stress Studies of Valacyclovir HCl in Bulk and Pharmaceutical Dosage Form Using RP-HPLC. International Journal of Pharmaceutical Sciences Review and Research. 2022;1-6. 10.47583/ijpsrr.2022.v76i01.001.
32. Sugumaran, M. and Bharathi, V. and Hemachander, R. and Lakshmi, M. RP-HPLC method for the determination of valacyclovir in bulk and pharmaceutical formulation. Der Pharma Chemica. 2011;3.190-194.
33. Bhavar, Girija and Pekamwar, Shriya and Aher, Kiran and Chaudhari, S.R. Development and validation of RP-HPLC method for the determination of valacyclovir hydrochloride and its related substances in tablet formulation. International Journal of Pharmaceutical Sciences Review and Research. 2014;25. 53-58.
34. Shaikh, S. S., Padri, V. K. "A validated stability indicating reverses phase liquid chromatographic method for the determination of valacyclovir." Int J Pharm Chem Anal 9, no. 2. 2022;71-78.
35. Deshpande, M.M., Kasture, V.S., Mohan, M. and Chaudhari, S. Development and validation of bioanalytical method for the determination of valcyclovir HCl in human plasma by liquid chromatoghraphy. Eur. J. Anal. Chem, 2015;10, pp.106-112.
36. Yadav, M., Upadhyay, V., Singhal, P., Goswami, S. and Shrivastav, P.S. Stability evaluation and sensitive determination of antiviral drug, valacyclovir and its metabolite acyclovir in human plasma by a rapid liquid chromatography–tandem mass spectrometry method. Journal of Chromatography B, 2009;877(8-9), pp.680-688.
37. Kanneti, R., Rajesh, R., Aravinda Raj, J.R. and Bhatt, P.A. An LC–MS–MS method for the simultaneous quantitation of acyclovir and valacyclovir in human plasma. Chromatographia, 2009;70(3), pp.407-414.
38. Konda, R.K., Chandu, B.R., Challa, B.R. and Chandrasekhar, K.B. Development and validation of a sensitive LC-MS/MS method for determination of valacyclovir in human plasma: Application to a bioequivalence study. Acta Chromatographica,2013; 25(4), pp.669-686.
39. Maria Kasiari, Evagelos Gikas, Sofia Georgakakou, Michael Kazanis, Irene Panderi, Selective and rapid liquid chromatography/negative-ion electrospray ionization mass spectrometry method for the quantification of valacyclovir and its metabolite in human plasma, Journal of Chromatography B, Volume 864, Issues 1–2,2008; Pages 78-86, ISSN 1570-0232.